False Claims Act & The Healthcare Industry, Second Edition 2012 Cumulative Supplement (Non-Members)
American Health Lawyers Association; Robert S. Salcido, Esq.
Price:
$149.00
Publisher:
AHLA
Format:
1 Volume, Softbound, 300 pages,BOOK
ISBN:
0006297971108 6/2012
Description
By Robert S. Salcido, Esq.
Significant events have occurred regarding the government's enforcement and administration of the False Claims Act (FCA) in the last few years. The government has continued to negotiate major settlements against healthcare entities. And the courts have issued numerous decisions that impact the manner in which healthcare businesses are organized and operated. In November 2011, the Department of Justice announced that since the FCA was substantially amended in 1986, it had recovered more than $30 billion under the FCA, and in 2011, it recovered $3 billion, of which $2.4 billion was from health-related FCA cases.
With these recent developments in FCA litigation and recoveries and the rapidly developing case law, you will need the Second Edition of False Claims Act & the Healthcare Industry and the 2012 Cumulative Supplement. This authoritative treatise will keep you up-to-date on the latest FCA developments so that you can more effectively advise your client on how to assess their company's potential exposure to liability, evaluate the exposure of companies that they may acquire, and reform company practices to reduce the risk of potential FCA liability.
The 2012 Cumulative Supplement covers:
• Congress' 2009 and 2010 FCA amendments, including a detailed discussion of the most likely legal consequences stemming from the amendments
• The latest cases applying the FCA in actions alleging a violation of the Anti-Kickback statute and Stark law
• Important defenses courts have applied dismissing actions because plaintiff failed to establish that any "false" claim was submitted or that defendant "knew" that the claim was false
• The latest cases dismissing FCA actions under the FCA public disclosure jurisdictional bar
• Cases addressing whether the plaintiff can establish that defendant retaliated against the plaintiff for investigating fraudulent conduct
• Critical cases discussing whether the tolling provisions of the FCA apply when the United States declines to intervene in a qui tam action
To purchase the Second Edition with 2012 Cumulative Supplement, click here.
Print this page
Email to a friend
